Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Glia. 2021 Oct;69(10):2362-2377. doi: 10.1002/glia.24042. Epub 2021 Jun 17.
Cerebral disease manifestation occurs in about two thirds of males with X-linked adrenoleukodystrophy (CALD) and is fatally progressive if left untreated. Early histopathologic studies categorized CALD as an inflammatory demyelinating disease, which led to repeated comparisons to multiple sclerosis (MS). The aim of this study was to revisit the relationship between axonal damage and myelin loss in CALD. We applied novel immunohistochemical tools to investigate axonal damage, myelin loss and myelin repair in autopsy brain tissue of eight CALD and 25 MS patients. We found extensive and severe acute axonal damage in CALD already in prelesional areas defined by microglia loss and relative myelin preservation. In contrast to MS, we did not observe selective phagocytosis of myelin, but a concomitant decay of the entire axon-myelin unit in all CALD lesion stages. Using a novel marker protein for actively remyelinating oligodendrocytes, breast carcinoma-amplified sequence (BCAS) 1, we show that repair pathways are activated in oligodendrocytes in CALD. Regenerating cells, however, were affected by the ongoing disease process. We provide evidence that-in contrast to MS-selective myelin phagocytosis is not characteristic of CALD. On the contrary, our data indicate that acute axonal injury and permanent axonal loss are thus far underestimated features of the disease that must come into focus in our search for biomarkers and novel therapeutic approaches.
脑疾病表现发生在大约三分之二的伴性连锁肾上腺脑白质营养不良(CALD)男性中,如果不治疗则会致命性进展。早期组织病理学研究将 CALD 归类为炎症性脱髓鞘疾病,这导致其与多发性硬化症(MS)进行了多次比较。本研究旨在重新审视 CALD 中轴突损伤和髓鞘丢失之间的关系。我们应用新的免疫组织化学工具来研究 8 例 CALD 和 25 例 MS 患者尸检脑组织中的轴突损伤、髓鞘丢失和髓鞘修复。我们发现,在由小胶质细胞丢失和相对髓鞘保留定义的发病前区域中,CALD 中已经存在广泛而严重的急性轴突损伤。与 MS 不同,我们没有观察到髓鞘的选择性吞噬,但在所有 CALD 病变阶段,整个轴突-髓鞘单位都同时发生退化。使用一种新的活跃性髓鞘形成少突胶质细胞标记蛋白,乳腺癌扩增序列 1(BCAS1),我们表明修复途径在 CALD 中的少突胶质细胞中被激活。然而,再生细胞受到持续疾病过程的影响。我们提供的证据表明,与 MS 相反,选择性髓鞘吞噬不是 CALD 的特征。相反,我们的数据表明,急性轴突损伤和永久性轴突丢失是该疾病迄今为止被低估的特征,在我们寻找生物标志物和新的治疗方法时必须关注这些特征。